U.S. Patent Issued For Viacreme; Natural Health Trends Corp. and 40J's LLC Announce Patent Approved for Viacreme Product DALLAS, Dec 5, 2001 (BW HealthWire) -- Natural Health Trends Corp. (OTCBB: NHTC) announced the receipt of the U.S. patent for Viacreme(TM). 40J's LLC and Lexxus International announced the issuance of Patent No. 6322493 for Viacreme. The patent, awarded to Viacreme formulator Dr. Ronald Thompson, was officially issued by the United States Patent and Trademark Office on Tuesday, November 27, 2001. "The issuance of a patent is a process that requires research, due diligence and time. The receipt of the Viacreme patent has been much anticipated by the entire Lexxus family," said Dr. Ronald Thompson. "We appreciate the patience of everyone who has followed our progress during this process and believe this patent further secures Viacreme as the only viable, recognized product of its kind in the marketplace," said Lexxus President and CEO Terry LaCore, pointing out Claim 14 in the patent information that provides protection for Viacreme with regard to the L-Arginine and Menthol ingredients. Claim 14 gives 40J's LLC and Lexxus International the substantiation and legal ground to prevent the marketing of any similar product by any other company. About Natural Health Trends Corp. Natural Health Trends Corporation is a holding company for two operating subsidiaries, ekaire.com, Inc., which sells nutritional supplements and vitamins, and Lexxus International, Inc. Lexxus, started in January 2001, markets and sells the revolutionary new product, Viacrème TM. Viacrème, developed by a leading gynecologist, is a quality-of-life product that improves the opportunity for women to achieve greater sexual satisfaction. Lexxus International has earned an estimated $17 million in revenues in just its first nine months of operation. The product, Viacrème, received a considerable amount of positive exposure including appearances on Good Morning Canada, FOX News and EXTRA, a leading television news magazine program. Lexxus International recently announced three additional products to its quality-of-life line. The three products are LaVie, a non-alcoholic Bordeaux manufactured with some of nature's most sensuous herbs; LexLips, a lip-gloss designed to give the appearance of full and luscious lips; and Skindulgence, a skin-care product with a blend of botanical extracts helping diminish the appearance of fine lines and wrinkles. Investors looking for information pertaining to Natural Health Trends Corp. or any of its subsidiaries are encouraged to look up www.nhtc.ws on the Internet or by contacting Investor Relations Services, Inc. at 386.409.0200 or on the Internet at www.invrel.net. Shareholders are encouraged to register for updated information on the corporation via e-mail at the website. When used in Form 10-QSB and in future filings by the Company with the Securities and Exchange Commission, the words ``will likely result,'' ``the Company expects,'' ``will continue,'' ``is anticipated,'' ``estimated,'' ``projected,'' ``outlook'' or similar expressions are intended to identify ``forward-looking statements'' within the meaning of the Private Securities Litigation Act of 1995. The Company wishes to caution readers not to place undue reliance on such forward-looking statements, each of which speak only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The Company has no obligation to publicly release the results of any revisions, which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements. CONTACT: Natural Health Trends Corp., Dallas Mark Woodburn, 972/819-2035 or Investor Relations Services, Inc., New Smyrna Beach, Fla. Tom Watkins, 386/409-0200 [email protected] |